Omofolasade Kosoko

642 total citations
8 papers, 484 citations indexed

About

Omofolasade Kosoko is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Omofolasade Kosoko has authored 8 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Ophthalmology, 4 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Omofolasade Kosoko's work include Glaucoma and retinal disorders (6 papers), Retinal Diseases and Treatments (3 papers) and Retinal Imaging and Analysis (2 papers). Omofolasade Kosoko is often cited by papers focused on Glaucoma and retinal disorders (6 papers), Retinal Diseases and Treatments (3 papers) and Retinal Imaging and Analysis (2 papers). Omofolasade Kosoko collaborates with scholars based in United States. Omofolasade Kosoko's co-authors include M. Roy Wilson, Claude L. Cowan, Dennis Ross‐Degnan, James F. Martone, Thomas O. Obisesan, Robert Hirsch, Cheryl Enger, Gleb Haynatzki, Chris A. Johnson and Pamela A. Sample and has published in prestigious journals such as Ophthalmology, Journal of the American Geriatrics Society and American Journal of Ophthalmology.

In The Last Decade

Omofolasade Kosoko

8 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omofolasade Kosoko United States 6 395 293 52 51 44 8 484
Aiming Chen China 11 242 0.6× 189 0.6× 9 0.2× 121 2.4× 36 0.8× 27 380
Cédric Benoist d’Azy France 4 175 0.4× 88 0.3× 9 0.2× 18 0.4× 76 1.7× 6 320
Yuko Gohto Japan 14 304 0.8× 174 0.6× 3 0.1× 36 0.7× 27 0.6× 26 451
Joseph Mancini Canada 5 41 0.1× 53 0.2× 7 0.1× 28 0.5× 116 2.6× 6 302
Séverine Bieuvelet France 6 21 0.1× 9 0.0× 49 0.9× 8 0.2× 40 0.9× 8 338
Youfan Ye China 8 22 0.1× 18 0.1× 2 0.0× 30 0.6× 7 0.2× 12 265
P.R. Pentel United States 8 5 0.0× 53 0.2× 6 0.1× 55 1.1× 20 0.5× 11 332
J. D. Fitzgerald Canada 10 8 0.0× 19 0.1× 18 0.3× 10 0.2× 10 0.2× 25 360
Maksymilian Onyszkiewicz Poland 9 19 0.0× 12 0.0× 10 0.2× 28 0.5× 56 1.3× 15 339
Daniel Wang United States 6 35 0.1× 11 0.0× 10 0.2× 12 0.2× 5 0.1× 23 211

Countries citing papers authored by Omofolasade Kosoko

Since Specialization
Citations

This map shows the geographic impact of Omofolasade Kosoko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omofolasade Kosoko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omofolasade Kosoko more than expected).

Fields of papers citing papers by Omofolasade Kosoko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omofolasade Kosoko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omofolasade Kosoko. The network helps show where Omofolasade Kosoko may publish in the future.

Co-authorship network of co-authors of Omofolasade Kosoko

This figure shows the co-authorship network connecting the top 25 collaborators of Omofolasade Kosoko. A scholar is included among the top collaborators of Omofolasade Kosoko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omofolasade Kosoko. Omofolasade Kosoko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wilson, M. Roy, Omofolasade Kosoko, Claude L. Cowan, et al.. (2002). Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in st. lucia, west indies. American Journal of Ophthalmology. 134(3). 399–405. 68 indexed citations
2.
Kosoko, Omofolasade, Harry A. Quigley, Susan Vitale, et al.. (1998). Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic. 11(28). 9 indexed citations
3.
Obisesan, Thomas O., et al.. (1998). Moderate Wine Consumption Is Associated with Decreased Odds of Developing Age‐Related Macular Degeneration in NHANES‐1. Journal of the American Geriatrics Society. 46(1). 1–7. 121 indexed citations
4.
Sekhsaria, Sudhir, et al.. (1992). An Unusual Case of Congenital Cytomegalovirus Infection with Glaucoma and Communicating Hydrocephalus. Clinical Pediatrics. 31(8). 505–507. 4 indexed citations
5.
Kosoko, Omofolasade, et al.. (1989). National Survey of the Prevalence and Risk Factors of Glaucoma in St. Lucia, West Indies. Ophthalmology. 96(9). 1363–1368. 246 indexed citations
6.
Robinson, Jeffrey D., et al.. (1989). Pasteurella multocida corneal ulcer following a baseball injury.. PubMed. 81(5). 609–10, 614. 2 indexed citations
7.
Kosoko, Omofolasade. (1986). Duration of Automated Suprathreshold vs Quantitative Threshold Field Examination. Archives of Ophthalmology. 104(3). 398–398. 12 indexed citations
8.
Kosoko, Omofolasade, Alfred Sommer, & Cheryl Auer. (1986). Screening with Automated Perimetry Using a Threshold-related Three-level Algorithm. Ophthalmology. 93(7). 882–886. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026